Science Explorer Back to mapMap
Discussion
Researcher · CIC bioGUNE · Spain

Leire Egia‐Mendikute

Leire Egia‐Mendikute publishes mostly in Immunology, Molecular Biology and Oncology, on topics such as Diabetes and associated disorders, Cancer, Hypoxia, and Metabolism and Immune cells in cancer.

ORCID 0000-0002-6435-1219 OpenAlex
World rank
#1,647,979
of 7,710,434 ranked researchers
Rank in Spain
#34,701
of 204,306
Works
106
Citations
506
Citations per work
4.8
h-index
14
i10-index 16Top 52% in Immunology
Leire Egia‐Mendikute

What does Leire Egia‐Mendikute research?

Leire Egia‐Mendikute's work is mostly in Biochemistry, Genetics and Molecular Biology (29%), Medicine (21%), Immunology and Microbiology (17%).

Life Sciences: 48 works · 45.7% of their workBiochemistry, Genetics and Molecular Biology: 31 works · 28.9% of their workMolecular Biology: 15 works · 14.0% of their workGenetics: 9 works · 8.4% of their workCancer Research: 7 works · 6.5% of their workImmunology and Microbiology: 18 works · 16.8% of their workImmunology: 18 works · 16.8% of their workEverything else: 36 works · 33.7% of their workHealth Sciences: 22 works · 20.6% of their workMedicine: 22 works · 20.6% of their workInfectious Diseases: 11 works · 10.3% of their workOncology: 11 works · 10.3% of their workTHEIR WORKLeireEgia‐Mendikute106works
Life Sciences46%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3128.9%
    2. Immunology and Microbiology1816.8%
  2. Everything else3633.7%
    1. Medicine2220.6%
  1. 1Immunology17% of their works
  2. 2Molecular Biology14% of their works
  3. 3Oncology10% of their works
  4. 4Infectious Diseases10% of their works
  5. 5Genetics8% of their works
  6. 6Cancer Research6% of their works

Research topics

Which keywords describe Leire Egia‐Mendikute's research?

The keywords of their largest research topics: Epidemiology, Type 1 Diabetes, Immunity, ACE2 Receptor, Inflammation, SARS-CoV-2, Autoimmunity and Genetics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Epidemiology112 topics
  2. Type 1 Diabetes102 topics
  3. Immunity92 topics
  4. ACE2 Receptor82 topics
  5. Inflammation82 topics
  6. SARS-CoV-282 topics
  7. Autoimmunity71 topic
  8. Genetics71 topic
  9. HIF-161 topic
  10. Warburg Effect61 topic
  11. Activation51 topic
  12. Macrophage51 topic
  13. Clinical Characteristics41 topic
  14. Coronavirus41 topic
  15. Thrombosis41 topic
  16. Vaccine41 topic
  17. Diabetes31 topic
  18. Hyaluronan31 topic
  19. Hypoglycemia31 topic
  20. Proteasome31 topic
  21. Proteoglycans31 topic
  22. Ubiquitin31 topic

Where does Leire Egia‐Mendikute work?

Leire Egia‐Mendikute's main affiliation in the publication record is CIC bioGUNE, Spain.

How many publications and citations does Leire Egia‐Mendikute have?

OpenAlex counts 106 works and 506 citations for Leire Egia‐Mendikute, an h-index of 14, ranking #1,647,979 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Leire Egia‐Mendikute. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.